Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

This year, one of the best watches unveiled at the show was a new Zenith Chronomaster Sport model. That was one of a pair of ...

A Federal High Court on Wednesday set aside its Mareva orders that froze $225.8 million in assets and accounts linked ...

In today's episode of Fratello Talks, the guys discuss this year's LVMH Watch Week ✓ Tune in to hear about all the new releases! ✓ ...

After a quick pivot away from its original LA venue, LVMH presented nine of its watch brands to press in New York. There, ...

Although street encampments and public drug use are top issues for Portland residents, the new City Council and mayor have ...

Justin Horowitz has been surfing the IOS wave with clients for five years now as it becomes an increasingly institutionalized ...

The Eola-Amity Hills Winegrowers Association is thrilled to announce the finalized lineup for its highly anticipated ...

Deeone announced that EFCC is currently investigating the Verydarkman's NGO and has a document to back it up. He noted that a ...

Japanese hitmaker KENSHI YONEZU, released a new song “BOW AND ARROW”, a song written as the theme song for the coming new anime series Medalist, streamed by Disney+ worldwide from Jan.4, today ...

Over the past few months, mobile network operators (MNOs) have raised concerns over the effect of the unpaid N250bn USSD ...